[SELL] Avangard: The struggle continues (June 4, 2015)

The recent figures for 1Q2015 showed that Avangard still experiences the consequences of the conflict in Eastern Ukraine, which brought the company’s laying hens flock down by  37% y/y, and  has not regained stability.  Furthermore, Avangard’s exports were greatly affected by the current situation in Middle East, which resulted in lower demand on dry egg products from countries such as Jordan. The company reported a  52% y/y drop in revenue to USD 72 mn and a 90% y/y drop in EBITDA to USD 6 mn in 1Q2015 (USD 17 mn excluding non-recurring items), while Avangard’s net loss for the quarter amounted to USD 52 mn.

The company’s operating cash flow before WC changes plunged by 87% y/y to USD 7 mn in 1Q2015, while net operating cash flow was negative at USD 3.3 mn, mainly as a result of a USD 28 mn increase in trade receivables and a USD 7.5 mn increase in inventories. This might signal that the liquidity squeeze going on in Ukraine has resulted in longer repayment period of accounts receivable.

The most worrying signal was the narrowing of gross margins for both of the company’s segments: gross profit margin of shell eggs decreased by 19 pp to 18%, while gross profit margin of dry egg products fell by 4pp to 31%. The key reason for this seems to be the lagging of price inflation as compared to the inflation of costs: while Avangard’s cost per egg increased by 130% y/y in UAH terms (to UAH 1.01/pcs), the average realized price of shell eggs grew by 60% y/y (to UAH 1.07/pcs). In this aspect the company looks weaker than its peer Ovostar, which reported an EBITDA margin of 52% in 1Q2015. 

Avangard’s poultry flock continued to shrink in 1Q2015: the company reported that its total flock decreased by 14% q/q to 20 mn, while Avangard’s laying hens flock decreased by 11% q/q to 16.6 mn, which was explained by the company’s management as an effort to adjust production volumes to the decreased internal demand. Furthermore, Avangard’s management plans to further decrease the laying hens flock to 14.6 mn by year-end, which does not seem logical to us as the company might lose its market share to other players.

The company’s export volumes remained weak in 1Q2015,  with just 108 mn of exported shell eggs (a 33% y/y decrease) and  2.1 ths tonnes of exported dry egg products  (-65% y/y). This resulted in a decrease in the share of export sales from 37% in 2014 to 33% in 1Q2015.

The company faces a serious liquidity problem, as it has to repay USD 66 mn of bank debt and USD 200 mn in Eurobonds in 2015, while Avangard’s cash balance amounted to USD 89.9 mn as of end-March 2015. On top of that, the company’s maintenance Capex comes to about USD 40 mn, most of which has to be spent to purchase equipment and spare parts from the European manufacturers. Thus, we expect Avangard to refinance its Eurobonds on less favorable conditions, probably with a longer maturity extension (5 years) and an amortization schedule. 

We estimate that Avangard’s revenues will fall by 27% y/y to USD 306 mn in 2015, mainly due to the decrease in production volumes. At the same time, we project that the company’s EBITDA will decline by 58% y/y to USD 54 mn as a result of an increase of production costs.  However, we expect net cash from operations to slightly decline to USD  39 mn in 2015 compared to USD 41 mn in 2014.

We downgrade our recommendation on Avangard to SELL on the basis of our DCF/Comparative valuation model (with each method having 50% weight), which puts the fair value of the company’s GDRs at USD 1.19 or 26% below the current price of USD 1.60.

 

Disclaimer

Although the information in this report has been obtained from sources which Empire State Capital Partners believes to be reliable and was collected in good faith, we do not represent or warrant its accuracy, except with respect to information concerning Empire State Capital Partners, its subsidiaries and affiliates, either expressly or implied, and such information may be incomplete or condensed. Nor has the information and/or data been independently verified, and so is provided without further caveat regarding its reliability, suitability for commerce or specific purpose. 

This report does not constitute a prospectus and is not intended to provide the sole basis for an evaluation of the securities discussed herein. All estimates and opinions included in this report constitute our judgment as of the date of the report and may be subject to change without notice. Empire State Capital Partners or its affiliates may, from time to time, have a position or make a market in the securities mentioned in this report, or in derivative instruments based thereon, may solicit, perform or have performed investment banking, or other services (including acting as advisor, manager) for any company referred to in this report and may, to the extent permitted by law, have used the information herein contained, or the research or analysis upon which it is based, before its publication. Empire State Capital Partners will not be responsible for the consequences of reliance upon any opinion or statement contained herein or for any omission. This report is confidential and is being submitted to select recipients only. It may not be reproduced (in whole or in part) without the prior written permission of Empire State Capital Partners.

Any recommendations, opinions, forecasts, estimates or views herein constitute a judgment as at the date of this report. This document has been produced independently of Empire State Capital Partners and the recommendations, forecasts, opinions, estimates, expectations, and views contained herein are entirely those of the research analyst(s). While all reasonable care has been taken to ensure that the facts presented herein are accurate and that the respective recommendations, forecasts, opinions, estimates, expectations, and views are fair and well considered, none of the research analyst(s), Empire State Capital Partners or any of its directors, managers or employees has verified the contents of this document and, accordingly, no research analyst, Empire State Capital Partners or any of its respective directors, managers or employees shall be in any way responsible for its contents.